Clinical Trials Browser

Phase 2 × Anal Canal Carcinoma × 30 days × Clear all

NCT02314169 2026-04-22

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Phase 2 Active not recruiting

143 enrolled 16 charts

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT02437851 2026-04-20

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Phase 2 Completed

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms, HIV Infections